OR WAIT null SECS
August 02, 2010
Industry's focus on cost cutting has led to a dangerous gap in training and knowledge.
Manufacturers and regulators on both sides of the ocean move to ensure the safety of heparin and other globally distributed drug products.
Chemocatalytic and biocatalytic approaches in asymmetric synthesis help provide a pathway for producing single-enantiomer drugs.
Green chemistry in pharmaceutical development often centers around approaches in the synthesis of the active ingredient, but green-chemistry techniques also can be applied to drug-product manufacturing, formulation development, and drug delivery.
August 01, 2010
As emerging markets become increasingly important for the pharmaceutical majors, companies are re-evaluating their outsourcing strategies. This article is part of the 2010 Outsourcing Resources special issue.
July 29, 2010
Merck and Sinopharm Sign Agreement; Agilent Appoints CFO; And More.
July 22, 2010
Pfizer Ends Second Tanezumab Clinical Program; Catalent VP Joins USP Panel; And More.
The Society of Chemical Manufacturers and Affiliates (SOCMA) expressed "strong concern" over legislation introduced in the US Senate earlier this month regarding chemical-site security.
Merck KGaA (Darmstadt, Germany), a global pharmaceutical and chemical company, completed its acquisition of Millipore (Billerica, MA), a life-science company, last Thursday for an aggregate purchase price of roughly EUR 5.2 billion ($6.7 billion).
July 15, 2010
Xcelience and Penn Form Joint Venture; Almac Appoints QA Director; And More.